Conferences - Results from #9900

AUA 2017: Does sarcopenia impact oncologic outcomes in patients undergoing adjuvant chemotherapy following radical cystectomy? May 30, 2017

AUA 2017: Late-Breaking Abstract – Interim results from a single-arm multicenter Phase II trial of CG0070, an oncolytic adenovirus, for BCG-unresponsive non-muscle-invasive bladder cancer (NMIBC) May 30, 2017

AUA 2017: Late-Breaking Abstract – Targeting epidermal growth factor receptor (EGFR) and human epidermal growth factor 2 expressing bladder cancer using combination photoimmunotherapy (PIT) May 30, 2017

AUA 2017: Late-Breaking abstract- A phase III blinded study of immediate post-TURBT instillation of gemcitabine versus saline in patients with newly diagnosed or occasionally recurring Grade I/II non-muscle invasive bladder cancer: SWOG S0337 May 30, 2017

AUA 2017: Best Abstract – Are the current follow-up guidelines after treatment for organ confined renal cancer sufficient? May 30, 2017

AUA 2017: Best Abstract – Liquid biopsy for renal cell carcinoma May 30, 2017

AUA 2017: A molecular scoring algorithm to predict survival in metastatic renal cell carcinoma May 30, 2017

AUA 2017: Thromboembolic events during treatment for renal cell carcinoma: must we prevent? May 30, 2017

AUA 2017: Can looks deceive? Not all clinically “cystic” renal masses harbor indolent biology May 30, 2017

AUA 2017: Differential gene expression in patients with indolent versus aggressive chromophobe renal cell carcinoma: An analysis of the cancer genome atlas database May 30, 2017

AUA 2017: A prospective study on the impact of radical cystectomy on sexual function in females with bladder cancer May 30, 2017

AUA 2017: National surgical quality improvement program surgical risk calculator poorly predicts complications in patients undergoing radical cystectomy with urinary diversion: the case for a procedure-specific risk calculator May 30, 2017

AUA 2017: Centralization of Radical Cystectomy for Bladder Cancer in a Universal Healthcare System: Early Results from a Canadian Academic Center May 29, 2017

AUA 2017: Early Cardiovascular Morbidity in a Pilot Prospective Randomized Trial Comparing LHRH Agonist and Antagonist Among Patients with Advanced Prostate Cancer. May 29, 2017

AUA 2017: Relationship Between Quality of Life and Overall Survival in Metastatic Castration-Resistant Prostate cancer patients in ALSYMPCA: Analysis by Prior Docetaxel Subgroup May 29, 2017

AUA 2017: Population-based analysis in treatment toxicity among men with castration-resistant prostate cancer May 29, 2017

AUA 2017: Late-Breaking Abstract- Blue Light Flexible Cystoscopy (BLFC) with Hexaminolevulinate (HAL) and White Light Flexible cystoscopy: A Prospective, Comparative, Within-Patient controlled Multi-Center Phase 3 Study in the Detection of Bladder Cancer May 29, 2017

AUA 2017: Novel therapies targeting androgen receptor variant in an in vitro model of castrate resistant prostate cancer. May 29, 2017

AUA 2017: Panel Discussion: Advances in Imaging in Urologic Oncology May 29, 2017

AUA 2017: A Comparison of Post-Cystectomy Recurrence and Survival in NAC-Responsive MIBC vs. High-Risk NMIBC Patients May 26, 2017

Page 496 of 624